These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3582420)

  • 1. The pharmacokinetics, tissue distribution, and biotransformation of a new class of antitumor agents: mitonafide and pinafide.
    Rivera Cid P; Gonzalez Fernandez E; Martin FR; Braña MF
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):255-67. PubMed ID: 3582420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic characterization of mitonafide in man.
    Brode E; Poveda Velasco A; Díaz-Rubio E; Rosell Costa R; Benavides Fissure A
    Methods Find Exp Clin Pharmacol; 1992 Mar; 14(2):131-40. PubMed ID: 1598025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of DNA strand breaks by mitonafide, an imide derivative of 3-nitro-1,8-naphthalic acid.
    Sinha BK; Strong J; Gibson NW; Kalyanaraman B
    Biochem Pharmacol; 1985 Nov; 34(21):3845-52. PubMed ID: 4062959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of the antiarrhythmic agent [3H]-diprafenone in the rat.
    Brunner F; Kolmayr U; Kukovetz WR
    Arzneimittelforschung; 1989 Nov; 39(11):1430-5. PubMed ID: 2619776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Amonafide in dogs.
    Lu K; McLean MA; Vestal ML; Newman RA
    Cancer Chemother Pharmacol; 1988; 21(2):134-8. PubMed ID: 3349561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative determination of two new antitumor agents from 1-8 naphthalimides in tablets. Validation of a high performance liquid chromatography method.
    Camacho MA; Torres AI; Gil ME; Obregón MM; Ruz V
    Arzneimittelforschung; 1994 May; 44(5):659-62. PubMed ID: 8024643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, metabolism and elimination of itanoxone in humans.
    Crawley FE; Hyacinthe R; Poitou P; Donath A
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):287-96. PubMed ID: 6653619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer.
    Rosell R; Carles J; Abad A; Ribelles N; Barnadas A; Benavides A; Martin M
    Invest New Drugs; 1992 Aug; 10(3):171-5. PubMed ID: 1330970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, enterohepatic circulation and biotransformation of [2-3H]-9,9-Dimethylacridane-10-carboxylic acid S-(2-dimethylamino) thiolethyl ester in the rat and dog.
    Farrier DS
    Arzneimittelforschung; 1977; 27(3):575-83. PubMed ID: 577424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of fosmidomycin, a new phosphonic acid, in rats and dogs.
    Tsuchiya T; Ishibashi K; Terakawa M; Nishiyama M; Itoh N; Noguchi H
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):59-64. PubMed ID: 7067725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
    Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
    Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the stable prostacyclin analogue, nileprost, in the rat.
    Krause W; Schulze PE; Totzek M
    Prostaglandins Leukot Med; 1983 Jul; 11(3):241-57. PubMed ID: 6351102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of antileukemic and trypanocidal compounds with amidino and imidazolinyl groups.
    Gluth WP; Busch U
    Arzneimittelforschung; 1984; 34(11):1542-51. PubMed ID: 6543129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
    Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog].
    Obermeier K; Niebch G; Thiemer K
    Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of 14C isobytylnaphtyl acetic acid in rat.
    Jacquot C; Payan-Lepain E; Christen MO; Achtert G; Hausleiter HJ; Borchers F
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):249-56. PubMed ID: 2633918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of DNA strand breaks and chromosome abnormalities by an imide derivative of 3-nitro-1,8-naphthalic acid (mitonafide) in Chinese hamster ovary cells.
    Nishio A; Uyeki EM
    J Natl Cancer Inst; 1983 Jun; 70(6):1097-102. PubMed ID: 6574279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies about the oral bioavailability of mitonafide and 2HCl amonafide, two new cytotoxic molecules.
    Torres Suárez AI; Camacho Sánchez MA
    Farmaco; 1992 Apr; 47(4):497-508. PubMed ID: 1388597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.